Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms
Clinical trial NCT07316088 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07316088
- Sponsor
- Oui Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-09
- Primary completion
- 2026-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.